Brief: QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals
07/02/2024 21:28
Feb 7 (Reuters) - Qsam Biosciences Inc QSAM.PK :
* QSAM BIOSCIENCES SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED
BY
TELIX PHARMACEUTICALS
* QSAM BIOSCIENCES INC - PURSUANT TO DEAL, QSAM
STOCKHOLDERS WILL
RECEIVE $33.1 MILLION IN TELIX ORDINARY SHARES OR CASH
* QSAM BIOSCIENCES- BY DEAL, QSAM STOCKHOLDERS WILL RECEIVE
CONTINGENT VALUE RIGHTS TO RECEIVE FUTURE PAYMENTS OF UP TO $90
MILLION UPON CERTAIN MILESTONES
Source text for Eikon: ID:nGNX8ytJL9
Further company coverage: QSAM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qsam Biosciences
See all newsBrief: QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals
Brief: Qsam Biosciences Says Co Granted Telix An Additional 30 Days Under Exclusivity Period To Complete Its Due Diligence
Brief: Qsam Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals Receives $2 Million Pre-Closing Collaboration And Option Fee
Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data